"Many organizations just pull a list of all available space and make you figure out which one fits your firm's needs. EDGE actually listened to our requirements and provided our organization with a summary of options that was in our target location, size and cost."
- Samuel Seymour, COO, Centurum
Melvin D. Booth, Chairman
–BIO
Real Estate
Mr. Booth has established unparalleled relationships within the biotechnology industry on local, national and international levels. Over the years, Mr. Booth was actively involved in expanding two of the most prominent Biotech companies in the Washington Metropolitan Area, Human Genome Sciences and MedImmune. Mr. Booth has extensive experience negotiating business incentives (local and state level) as well as creative financing and venture capital solutions.
Mr. Booth was President and Chief Operating Officer of MedImmune, Inc. from 1998 to 2004 and a member of the Board of Directors for MedImmune, Inc. from November 1998 through March 2005. The company is one of the largest and most successful biotechnology companies in the world. Dedicated to advancing science and medicine to help people live better lives, MedImmune (acquired by AstraZeneca PLC on June 2007) is focused on pediatric infectious diseases, cancer and inflammatory diseases with approximately 3,000 employees worldwide and is headquartered in Maryland.
Prior to joining MedImmune, Mr. Booth was President and Chief Operating Officer of Human Genome Sciences, Inc. where he was also a member of the Executive Committee and Board of Directors. From 1975 to 1995, he was employed at Syntex Corporation. He held a variety of positions, including President of Syntex Laboratories, Inc., President of Syntex, Inc., Canada and Vice President of Syntex Corporation.
Mr. Booth has been active in U.S. pharmaceutical industry organizations and is a past Chairman of the Pharmaceutical Manufacturers Association of Canada. He currently serves on the Strategic Advisory Committee for Genstar Capital, as a Director on the board of Ventria BioScience, as Lead Director of Millipore Corporation and Chairman of the Boards of Prestwick Pharmaceuticals, Inc. and PRA International, Inc.
Mr. Booth graduated with honors and holds an honorary Doctor of Science degree from Northwest Missouri State University. Mr. Booth is a Certified Public Accountant.
Back to Bios
